2 results
8-K
EX-99.1
VKTX
Viking Therapeutics Inc
17 Feb 21
Viking Therapeutics Reports Fourth Quarter and Year-End 2020 Financial Results and Provides Corporate Update
4:12pm
ethnicity.
The overall results from this study, including these durability data, as well as the observed consistent efficacy across high risk
8-K
EX-99.1
VKTX
Viking Therapeutics Inc
28 Oct 20
Viking Therapeutics Reports Third Quarter 2020 Financial Results and Provides Corporate Update
4:10pm
(BMI) ≥ 30, hypertension and Hispanic ethnicity.
The overall results from this study, including these new durability data, as well as the observed
- Prev
- 1
- Next